Eun Jin, Lee Jung Eun, Yang Seung Ho
Department of Neurosurgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Neurosurgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Clin Exp Pediatr. 2025 Apr;68(4):269-277. doi: 10.3345/cep.2024.01235. Epub 2024 Nov 28.
Cerebral organoids derived from human induced pluripotent stem cells offer a groundbreaking foundation for the analysis of pediatric neurological diseases. Unlike organoids from other somatic systems, cerebral organoids present unique challenges, such as the high sensitivity of neuronal cells to environmental conditions and the complexity of replicating brain-specific architectures. Cerebral organoids replicate the human brain development and pathology, enabling research on conditions such as microcephaly, Rett syndrome, autism spectrum disorders, and brain tumors. This review explores the utility of cerebral organoids for modeling diseases and testing therapeutic interventions. Despite current limitations such as variability and lack of vascularization, recent technological advancements have improved the reliability and application of such interventions. Cerebral organoids provide valuable insight into the mechanisms underlying complex neural disorders and hold promise as novel treatment strategies for pediatric neurological diseases.
源自人类诱导多能干细胞的大脑类器官为小儿神经疾病的分析提供了一个开创性的基础。与其他体细胞系统的类器官不同,大脑类器官存在独特的挑战,例如神经元细胞对环境条件的高度敏感性以及复制脑特异性结构的复杂性。大脑类器官复制了人类大脑发育和病理学,能够对小头畸形、雷特综合征、自闭症谱系障碍和脑肿瘤等病症进行研究。本综述探讨了大脑类器官在疾病建模和测试治疗干预方面的效用。尽管目前存在诸如变异性和缺乏血管化等局限性,但最近的技术进步提高了此类干预的可靠性和应用。大脑类器官为复杂神经疾病的潜在机制提供了有价值的见解,并有望成为小儿神经疾病的新型治疗策略。